Jacob Hochman

2.2k total citations
73 papers, 1.7k citations indexed

About

Jacob Hochman is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jacob Hochman has authored 73 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 24 papers in Oncology and 18 papers in Immunology. Recurrent topics in Jacob Hochman's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Immunotherapy and Immune Responses (11 papers) and Metal complexes synthesis and properties (10 papers). Jacob Hochman is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Immunotherapy and Immune Responses (11 papers) and Metal complexes synthesis and properties (10 papers). Jacob Hochman collaborates with scholars based in Israel, United States and Germany. Jacob Hochman's co-authors include David Givol, Dan Inbar, Edit Y. Tshuva, Ori Braitbard, Michael M. Gottesman, Aviva Katz, Joseph Schlessinger, Izchak Z. Steinberg, Israel Pecht and Henry R. Bourne and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jacob Hochman

70 papers receiving 1.6k citations

Peers

Jacob Hochman
Attila Nagy United States
Frédéric Lopez France
Weiping Jiang United States
Verena Staedtke United States
Rolf Jaussi Switzerland
Tomoko Ise Japan
Bruno Tocqué France
Christopher J. Brown Singapore
Laura Cerchia Italy
Attila Nagy United States
Jacob Hochman
Citations per year, relative to Jacob Hochman Jacob Hochman (= 1×) peers Attila Nagy

Countries citing papers authored by Jacob Hochman

Since Specialization
Citations

This map shows the geographic impact of Jacob Hochman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Hochman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Hochman more than expected).

Fields of papers citing papers by Jacob Hochman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Hochman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Hochman. The network helps show where Jacob Hochman may publish in the future.

Co-authorship network of co-authors of Jacob Hochman

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Hochman. A scholar is included among the top collaborators of Jacob Hochman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Hochman. Jacob Hochman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braun, Maya, Emiliano Cohen, Ori Braitbard, et al.. (2020). Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug. iScience. 23(7). 101262–101262. 27 indexed citations
2.
Lawson, James S., Chiara Maria Mazzanti, Prospero Civita, et al.. (2018). Association of Mouse Mammary Tumor Virus With Human Breast Cancer: Histology, Immunohistochemistry and Polymerase Chain Reaction Analyses. Frontiers in Oncology. 8. 141–141. 17 indexed citations
3.
Meker, Sigalit, Ori Braitbard, Matthew D. Hall, Jacob Hochman, & Edit Y. Tshuva. (2016). Specific Design of Titanium(IV) Phenolato Chelates Yields Stable and Accessible, Effective and Selective Anticancer Agents. Chemistry - A European Journal. 22(29). 9849–9849. 5 indexed citations
4.
Braitbard, Ori, et al.. (2016). Insights into molecular mechanism of action of salan titanium(IV) complex with in vitro and in vivo anticancer activity. Journal of Inorganic Biochemistry. 163. 250–257. 27 indexed citations
5.
Aronow, Mary E., Defen Shen, Jacob Hochman, & Chi‐Chao Chan. (2015). Intraocular Lymphoma Models. Ocular Oncology and Pathology. 1(3). 214–222. 2 indexed citations
6.
Meker, Sigalit, Katrin Margulis‐Goshen, Ori Braitbard, et al.. (2014). Anti‐proliferative Activity of Nano‐Formulated Phenolato Titanium(IV) Complexes Against Cancer Cells. ChemMedChem. 9(6). 1294–1298. 26 indexed citations
7.
Roniger, Maayan, et al.. (2012). The Signal Peptide of Mouse Mammary Tumor Virus-Env: A Phosphoprotein Tumor Modulator. Molecular Cancer Research. 10(8). 1077–1086. 20 indexed citations
8.
Wellhöner, Hans H., Aryeh Weiss, Axel Schulz, et al.. (2012). Reversing ABCB1-mediated multi-drug resistance from within cells using translocating immune conjugates. Journal of drug targeting. 20(5). 445–452. 7 indexed citations
9.
Hochman, Jacob, Defen Shen, Michael M. Gottesman, & Chi‐Chao Chan. (2012). Anti-LFA-1 antibodies enhance metastasis of ocular lymphoma to the brain and contralateral eye. Clinical & Experimental Metastasis. 30(1). 91–102. 6 indexed citations
10.
11.
Nussenblatt, Robert B., et al.. (2006). International Central Nervous System and Ocular Lymphoma Workshop: Recommendations for the Future. Ocular Immunology and Inflammation. 14(3). 139–144. 32 indexed citations
12.
13.
14.
Rorman, Efrat, et al.. (1998). Nucleolar Localization of Mouse Mammary Tumor Virus Proteins in T-Cell Lymphomas. Virology. 242(2). 246–254. 12 indexed citations
15.
Weiss, Aryeh, Knut Adermann, Georg Erdmann, et al.. (1998). Translocation of acylated pardaxin into cells. FEBS Letters. 440(1-2). 131–134. 3 indexed citations
16.
Pe’er, Jacob, et al.. (1997). An experimental model for infiltration of malignant lymphoma to the eye and brain. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 431(6). 459–467. 21 indexed citations
17.
Mador, Nurith, et al.. (1997). Variant mouse lymphoma cells with modified response to interferon demonstrate enhanced immunogenicity. Cancer Immunology Immunotherapy. 44(5). 249–256. 5 indexed citations
18.
Hochman, Jacob, et al.. (1990). Monoclonal Antibodies to Immunogenic Lymphoma Cell Variants Displaying Impaired Neoplastic Properties: Characterization and Applications. JNCI Journal of the National Cancer Institute. 82(23). 1821–1826. 18 indexed citations
19.
Ginsburg, Malka, Jacob Hochman, & Hefzibah Eyal‐Giladi. (1989). Immunohistochemical analysis of the segregation process of the quail germ cell lineage. The International Journal of Developmental Biology. 33(3). 389–395. 12 indexed citations
20.
Hochman, Jacob, et al.. (1988). Isolation and characterization of interferon-resistant variants from S49 mouse lymphoma. Experimental Cell Research. 177(1). 37–46. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Attila Nagy Breakdown of academic impact, for papers by Frédéric Lopez Breakdown of academic impact, for papers by Weiping Jiang Breakdown of academic impact, for papers by Verena Staedtke Breakdown of academic impact, for papers by Rolf Jaussi Breakdown of academic impact, for papers by Tomoko Ise Breakdown of academic impact, for papers by Bruno Tocqué Breakdown of academic impact, for papers by Christopher J. Brown Breakdown of academic impact, for papers by Laura Cerchia
Rankless by CCL
2026